Answers are grounded in this paper and cite their sources.
Deep fascia fibrosis is a pathological feature of multiple musculoskeletal disorders, including gluteal muscle contracture (GMC), Dupuytren’s disease, myofascial pain syndrome, and plantar fasciitis. However, the stromal cell mechanisms that maintain fascial homeostasis and drive pathological remodeling remain poorly understood. Telocytes (TCs) are specialized interstitial stromal cells characterized by exceptionally long, moniliform cellular processes termed telopodes, which form extensive intercellular networks within connective tissues. Despite their presence in deep fascia, their involvement in fascial fibrosis remains unknown. We integrated ultrastructural analysis and single-cell transcriptomics profiling of human GMC-associated fibrotic deep fascia, with validation in a rat model of GMC and functional studies using primary fascia-derived cells. Transmission electron microscopy revealed increased near-somatic telopode discontinuities in human GMC fascia compared with controls (1.53 ± 0.30 vs. 0.43 ± 0.23 per TC; GMC, n = 4; control, n = 3; p < 0.05), with a similar increase in GMC rats (1.67 ± 0.15 vs. 0.08 ± 0.03 per TC; n = 4 per group; p < 0.0001). Immunofluorescence analysis demonstrated a 94% reduction in continuously connected telopode length in fibrotic fascia (3.19 ± 1.13 vs. 58.84 ± 9.48 μm; p < 0.01). Single-cell RNA sequencing showed that TCs were largely preserved in abundance but exhibited an altered transcriptional state characterized by enhanced TGF-β signaling and acquisition of a profibrotic extracellular matrix remodeling program. In primary fascia-derived cells exhibiting TC-like characteristics (n = 3 independent isolations), TGF-β1 increased the proportion of cells with fragmented telopodes from 26.29 ± 4.98% to 92.56 ± 1.68% (p < 0.0001). Treatment with the TGF-β receptor inhibitor SB431542 reduced this proportion to 22.00 ± 5.18%, representing a 76% relative reduction compared with TGF-β1 treatment alone (p < 0.0001). Our findings identify TGF-β-associated telocyte pathological reprogramming and TGF-β-driven telocyte degeneration as a previously unrecognized feature of deep fascia fibrosis. We propose that aberrant TGF-β signaling promotes a pathological telocyte state characterized by loss of telopode integrity and enhanced ECM-remodeling potential, thereby contributing to remodeling of the fibrotic fascial microenvironment.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: